1.Analysis of influencing factors of preparation quality of gastric mucosa during gastroscopy
Xi ZHOU ; Pingping CHEN ; Caixiu GUO ; Yinyin LI ; Xiaohui JIN ; Yang LIU
Chongqing Medicine 2025;54(10):2371-2375
Objective To explore the influencing factors of the quality of gastric mucosal preparation before gastroscopy on the clarity of gastric mucosa under gastroscopy.Methods Clinical data of 240 patients who underwent painless gastroscopy for the first time at the endoscopy center of a tertiary hospital in Wenzhou from September 1,2023 to December 31,2024 were analyzed.The mucosal clarity score under gas-troscopy was recorded during the gastroscopy process,and the influencing factors on the qualification rate of gastric mucosal preparation quality for painless gastroscopy were analyzed.Results The unqualified rate of gastric mucosal preparation in patients undergoing painless gastroscopy was 52.9%,with the highest rates in the upper part of the stomach(17.1%)and the bottom of the stomach(12.1%),followed by the lower part of the stomach(9.2%),the antrum(7.9%)and bulb(3.8%),the lowest rates in the esophagus(2.9%).The quality of gastric mucosal preparation was relatively poor.Multivariate logistic regression analysis showed that,BMI,Helicobacter pylori(Hp)infection,abnormal gastric juice characteristics,and gastric polyps were independent risk factors affecting gastric mucosal preparation(OR=2.784,3.501,3.873,3.611,P<0.05).Conclusion Insufficient preparation of gastric mucosa is associated with high BMI,Hp infection,abnormal gastric juice characteristics,and gastric polyps.To address patients with these risk factors,individualized pre-treatment plans should be developed based on routine fasting to optimize endoscopic field of view and ensure examination quality.
2.Observation on cervical progressing suture in treating intractable cervical canal hemorrhage during cesarean section in 30 cases of placenta previa
Caixiu PU ; Mingbo LIU ; Xiuquan LI ; Wei ZHOU
Chongqing Medicine 2017;46(22):3083-3084,3087
Objective To explore the haemostatic efficacy of cervical progressing suture in treating intractable cervical canal hemorrhage during cesarean section(CS) in placenta previa.Methods Sixty patients suffering from intractable cervical canal hemorrhage during CS due to central placenta previa were chosen and divided into the cervical progressing suture(observation roup,30 cases) and the uterine cavity ribbon gauze packing group(control group,30 cases).The intraoperative operating time,intraoperative bleeding amount,postoperative 24 h hemorrhage amount,hysterectomy and puerperal infection were compared between the two groups.Results The intraoperative operation time in the observation group and control group were (3.15± 1.60)min and (6.10±2.35) min respectively,the intraoperative bleeding amount in the observation group and control group were (422.00 ±-186.98)mL and (642.25±344.42)mL respectively,postoperative 24 h bleeding amounts were (583.23±=198.33)mL and (825.23±=373.50)mL respectively,the differences between the two groups were statistically significant(P<0.05).No hysterectomy and no complications ocurred in each group.Conclusion Adopting the cervical progressing suture in treating intractable cervical canal hemorrhage during cesarean section(CS) due to placenta previa is simple to operate and has good effect.
3.Similarity and diversity analysis of qingkailing effective components in regulating hippocampus ischemia-related genes of mice.
Caixiu ZHOU ; Zhong WANG ; Zhanjun ZHANG ; Zhiwei JING
China Journal of Chinese Materia Medica 2010;35(18):2475-2479
OBJECTIVETo compare the different gene expression profiles among Qingkailing components of BA (baicalin), JA (jasminoidin), CA (cholic acid) and CM (concha margaritiferausta) in regulating hippocampus ischemia related genes of mice.
METHODThe hippocampus ischemia-reperfusion model mice were randomly divided into groups of BA, JA, CA, CM and M (model group), 15 mice for each group, and decapitated after 24 hours. Coronal brain slices were stained with TTC (2, 3, 5-Triphenylte trazolium Chloride) and the percentages of infarct volume were calculated. Meanwhile, total RNA were extracted from the hippocampus. We selected 374 genes which related to cerebral ischemia to find the different gene expression profiles among the Qingkailing components. Then T-tests was used to select different genes between BA and CM, JA and CM, CA and CM by Arraytrack software (P < 0. 05, Fold change > 1.5), and the pharmacodynamic characteristics were explored according to GO functional classification.
RESULTCompared with the model group BA, JA and CA could effectively reduce infarct size of hippocampus ischemic (P < 0.05). the numbers of significantly differentially expressed genes were 41 (24 up, 17 down) between BA and CM, 22 (13 up, 9 down) between JA and CM, and 11(8 up, 3 down) between CA and CM. All of BA, JA and CA could inhibit the expression of Myb gene.
CONCLUSIONWhen exerting its pharmacological effects, BA, JA, CA not only have common gene targets but also have diversity in pharmacological character.
Animals ; Brain Ischemia ; drug therapy ; genetics ; metabolism ; Disease Models, Animal ; Drugs, Chinese Herbal ; pharmacology ; Gene Expression Regulation ; drug effects ; Hippocampus ; blood supply ; drug effects ; metabolism ; Humans ; Male ; Mice ; Random Allocation
4.Differences in pharmacological pathways among Qingkailing effective component
Caixiu ZHOU ; Zhong WANG ; Zhiwei JING ; Zhanjun ZHANG
Chinese Pharmacological Bulletin 2010;26(4):547-551
AimPurpose-The aim of this study is utilizing the highthrough genechip data to Compare the difference of the pharmacological pathways among the Qingkailing effective components Baicalin(BA),Jasminoidin(JA),cholic acid(CA) and Concha margaritiferausta(CM)in the treatment process of cerebral ischemia.Methods The focal cerebral ischemia-reperfusion model mice were randomly divided into groups of Baicalin(BA),Jasminoidin(JA),cholic acid(CA),Concha margaritiferausta(CM)and model group(M),15 mice for each group,24 hours later total RNA were abstracted from the hippocampus,we selected 374 gene expression profile related to cerebral ischemia,made cDNA chip marked by Cy3/Cy5,detect the variation of different components,Then apply Arraytrack software to select differentiate expressed genes between BA and M,JA and M,CA and M,CM and M by T-tests,select genes with P<0.05,Fold change>1.5,according GeneGO software to find the top two pathways of each components.Results the number of differentiate expressed genes between BA,JA,CA,CM and M is separately 46,50,54 and 30,according to the top two pathways of GeneGo display JA,CA,CM all participate Apoptosis and survival_TNFR1 signaling pathway,besides BA participate in regulating G-protein signaling and Development_A2A receptor signaling while CA in Neurophysiological process_NMDA-dependent postsynaptic long-term potentiation in CA1 hippocampal.Conclusion Qingkailing effective components take diversity Pharmacological characteristics,BA mainly for anti-apoptosis,JA mainly for inhibit apoptosis and promote ischemic brain protection,etc,CA focused on inhibiting calcium influx,and anti-neuron variability.But CM has no good results on this.

Result Analysis
Print
Save
E-mail